Human Vaccines & Immunotherapeutics, Volume 8, Issue 12 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Human Vaccines & Immunotherapeutics, Volume 8, Issue 12 (2012)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Volume 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editor's Corner

Editorial
Letter from the Editor
Ronald Ellis & Eva M. Riedmann
Pages: 1739-1740
Published online: 01 Dec 2012
CitationforLetter from the Editor | Full Text | PDF (103.5 KB)
  • 314 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

News, Policy & Profiles

News
Human Vaccines & Immunotherapeutics
News
Eva M. Riedmann
Pages: 1741-1744
Published online: 01 Dec 2012
AbstractforHuman Vaccines & Immunotherapeutics | Full Text | PDF (114.6 KB)
  • 1101 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
News
Profile
ImmunoCellular Therapeutics Ltd.
John S. Yu
Page: 1745
Published online: 01 Dec 2012
CitationforProfile | Full Text | PDF (87.4 KB)
  • 474 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Therapeutic vaccination to treat chronic infectious diseases
Current clinical developments using MVA-based vaccines
Houda Boukhebza, Nadine Bellon, Jean Marc Limacher & Geneviève Inchauspé
Pages: 1746-1757
Published online: 16 Aug 2012
AbstractforTherapeutic vaccination to treat chronic infectious diseases | Full Text | References | PDF (1.7 MB)
  • 1557 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Universal fungal vaccines
Could there be light at the end of the tunnel?
Mawieh Hamad
Pages: 1758-1763
Published online: 24 Aug 2012
AbstractforUniversal fungal vaccines | Full Text | References | PDF (635.2 KB)
  • 774 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Short Report

Brief Report
A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits
Kanakatte Raviprakash, Thomas Luke, John Doukas, Janine Danko, Kevin Porter, Timothy Burgess & Tadeusz Kochel
Pages: 1764-1768
Published online: 02 Oct 2012
AbstractforA dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits | Full Text | References | PDF (1.2 MB)
  • 623 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines
Mona E.E. Elfaki, Eltahir A.G. Khalil, Anne S. De Groot, Ahmed M. Musa, Andres Gutierrez, Brima M. Younis, Kawthar A.M. Salih & Ahmed M. El-Hassan
Pages: 1769-1774
Published online: 24 Aug 2012
AbstractforImmunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines | Full Text | References | PDF (648.1 KB)
  • 1031 Views
  • 28 CrossRef citations
  • 0Altmetric
Free Access

Commentary

Production of EV71 vaccine candidates
Pele Chong, Shih-Yang Hsieh, Chia-Chyi Liu, Ai-Hsiang Chou, Jui-Yuan Chang, Suh-Chin Wu, Shih-Jen Liu, Yen-Hung Chow, Ih-Jen Su & Michel Klein
Pages: 1775-1783
Published online: 19 Sep 2012
AbstractforProduction of EV71 vaccine candidates | Full Text | References | PDF (209.1 KB)
  • 3343 Views
  • 61 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Immune reconstitution and vaccination outcome in HIV-1 infected children
Present knowledge and future directions
Alberto Cagigi, Nicola Cotugno, Carlo Giaquinto, Luciana Nicolosi, Stefania Bernardi, Paolo Rossi, Iyadh Douagi & Paolo Palma
Pages: 1784-1794
Published online: 21 Aug 2012
AbstractforImmune reconstitution and vaccination outcome in HIV-1 infected children | Full Text | References | PDF (684.5 KB)
  • 1028 Views
  • 35 CrossRef citations
  • 0Altmetric
Free Access

Commentary

HIV vaccines
Can CD4+ T cells be of help?
Eva Van Braeckel & Geert Leroux-Roels
Pages: 1795-1798
Published online: 21 Aug 2012
AbstractforHIV vaccines | Full Text | References | PDF (599.4 KB)
  • 570 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Case Report

Case Report
CIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma
Jian Y. Cheng & Ratnavelu Kananathan
Pages: 1799-1801
Published online: 21 Aug 2012
AbstractforCIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma | Full Text | References | PDF (698.9 KB)
  • 1457 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Prevention of infection in immunosuppressive patients with autoimmune nephrosis by using an immunostimulating bacterial lysate Broncho-vaxom
Miao Zhang, Hong Luan, Qian Zhang, Le Wang, Yong-Man Lv, Fan He, Yan Chen, Hong-Bing Zeng, Ying Yao & Qin Liu
Pages: 1802-1807
Published online: 24 Aug 2012
AbstractforPrevention of infection in immunosuppressive patients with autoimmune nephrosis by using an immunostimulating bacterial lysate Broncho-vaxom | Full Text | References | PDF (1.3 MB)
  • 980 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Maturation of morphology, phenotype and functions of murine bone marrow-derived dendritic cells(DCs) induced by polysaccharide Kureha(PSK)
Yonggang Tan, Yiming Meng, Zuozhou Wang, Fengping Shan, Qiushi Wang & Ning Zhang
Pages: 1808-1816
Published online: 02 Oct 2012
AbstractforMaturation of morphology, phenotype and functions of murine bone marrow-derived dendritic cells(DCs) induced by polysaccharide Kureha(PSK) | Full Text | References | PDF (1.3 MB)
  • 756 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Phage display—A powerful technique for immunotherapy
1. Introduction and potential of therapeutic applications
Justyna Bazan, Ireneusz Całkosiński & Andrzej Gamian
Pages: 1817-1828
Published online: 21 Aug 2012
AbstractforPhage display—A powerful technique for immunotherapy | Full Text | References | PDF (918 KB)
  • 10467 Views
  • 150 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Phage display—A powerful technique for immunotherapy
2. Vaccine delivery
Justyna Bazan, Ireneusz Całkosiński & Andrzej Gamian
Pages: 1829-1835
Published online: 21 Aug 2012
AbstractforPhage display—A powerful technique for immunotherapy | Full Text | References | PDF (633.5 KB)
  • 3131 Views
  • 28 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®
Jun-Yu Wu, Yan Liu, Jiang-Ting Chen, Ming Xia & Xiao-Mei Zhang
Pages: 1836-1844
Published online: 02 Oct 2012
AbstractforReview of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive® | Full Text | References | PDF (1 MB)
  • 1120 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule
Ke Han, Xiaoping Shao, Huizhen Zheng, Chenggang Wu, Jianqiong Zhu, Xiaoli Zheng & Yonghui Zhang
Pages: 1845-1849
Published online: 21 Aug 2012
AbstractforRevaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule | Full Text | References | PDF (612.1 KB)
  • 1092 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access
Article
Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season
Jill J. Severson, Katelyn R. Richards, John J.M. Moran & Mary S. Hayney
Pages: 1850-1853
Published online: 21 Aug 2012
AbstractforPersistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season | Full Text | References | PDF (592.1 KB)
  • 585 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand
Nuntisa Chotirosniramit, Patcharaphan Sugandhavesa, Linda Aurpibul, Sunida Thetket, Natthapol Kosashunhanan, Taweewat Supindham, Panuwat Wongkulab, Quanhathai Kaewpoowat, Kanokporn Chaiklang, Oranitcha Kaewthip, Piyathida Sroysuwan, Antika Wongthanee, Hatairat Lerdsamran, Pilaipan Puthavathana & Khuanchai Suparatpinyo
Pages: 1854-1859
Published online: 21 Aug 2012
AbstractforImmune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand | Full Text | References | PDF (621.1 KB)
  • 579 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Acceptance and rejection of influenza vaccination by pregnant women in southern Iran
Physicians' role and barriers
Behnam Honarvar, Neda Odoomi, Mojtaba Mahmoodi, Golnar Sami Kashkoli, Fatemeh Khavandegaran, Kamran Bagheri Lankarani & Mohsen Moghadami
Pages: 1860-1866
Published online: 02 Oct 2012
AbstractforAcceptance and rejection of influenza vaccination by pregnant women in southern Iran | Full Text | References | PDF (665.8 KB)
  • 858 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Short Report

Brief Report
Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?
Ala-Eddin Al Moustafa, Amber Yasmeen, Lina Ghabreau & Nizar Akil
Pages: 1867-1868
Published online: 02 Oct 2012
AbstractforDoes the Syrian population have to wait for the new generation of human papillomaviruses vaccine? | Full Text | References | PDF (549.1 KB)
  • 420 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Research Paper

Article
Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice
Jiuling Wang, Yaqing Qie, Wei Liu & Honghai Wang
Pages: 1869-1874
Published online: 21 Aug 2012
AbstractforProtective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice | Full Text | References | PDF (1.1 MB)
  • 584 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults
New considerations for the management of patients with tetanus-prone injuries
Henri Laurichesse, Ulrich Zimmermann, Florence Galtier, Odile Launay, Xavier Duval, Patrick Richard, Christine Sadorge & Benoit Soubeyrand
Pages: 1875-1881
Published online: 02 Oct 2012
AbstractforImmunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults | Full Text | References | PDF (785.4 KB)
  • 874 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 years
Timo Vesikari, Aino Forstén, Dominique Boutriau, Véronique Bianco, Marie Van der Wielen & Jacqueline M. Miller
Pages: 1882-1891
Published online: 02 Oct 2012
AbstractforA randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 years | Full Text | References | PDF (697.3 KB)
  • 982 Views
  • 26 CrossRef citations
  • 0Altmetric
Open Access
Article
Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers
Timo Vesikari, Aino Forstén, Dominique Boutriau, Véronique Bianco, Marie Van der Wielen & Jacqueline M. Miller
Pages: 1892-1903
Published online: 02 Oct 2012
AbstractforRandomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers | Full Text | References | PDF (404.6 KB)
  • 1172 Views
  • 36 CrossRef citations
  • 0Altmetric
Open Access

Commentary

Meningococcal vaccine
A new vaccine to combat meningococcal disease in India
Ramesh Verma & Pardeep Khanna
Pages: 1904-1906
Published online: 01 Dec 2012
AbstractforMeningococcal vaccine | Full Text | References | PDF (583.8 KB)
  • 1028 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Meningococcal serogroup Y emergence in Europe
Update 2011
Michael Bröker, Susanne Jacobsson, Markku Kuusi, David Pace, Maria J. Simões, Anna Skoczynska, Muhamed-Kheir Taha, Maija Toropainen & Georgina Tzanakaki
Pages: 1907-1911
Published online: 02 Oct 2012
AbstractforMeningococcal serogroup Y emergence in Europe | Full Text | References | PDF (865.8 KB)
  • 1098 Views
  • 33 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses
David Fisman et al.
Review Article | Published online: 4 Jun 2024
Open Access
Vaccination status and disease severity of COVID-19 in different phases of the pandemic
Xueying Yang et al.
Article | Published online: 4 Jun 2024
Open Access
Predictors of parental acceptance to live attenuated influenza vaccine for children
Shujuan Qu et al.
Article | Published online: 4 Jun 2024
Open Access
Inactivated influenza virus vaccines expressing COBRA hemagglutinin elicited broadly reactive, long-lived protective antibodies
Hua Shi et al.
Article | Published online: 2 Jun 2024
Open Access